A - Human Necessities – 61 – K
Patent
A - Human Necessities
61
K
A61K 47/48 (2006.01) A61K 31/7056 (2006.01) A61P 31/14 (2006.01) A61K 38/21 (2006.01)
Patent
CA 2334267
The present invention provides the use of PEG-IFN-.alpha. conjugates in association with Ribavirin for the manufacture of medicaments for the treatment of chronic hepatitis C infections. The present invention also provides a method for treating chronic hepatitis C infections in patients in need of such treating comprising administering an amount of PEG- IFN-.alpha. conjugate in association with an amount of Ribavirin effective to treat hepatitis C.
La présente invention concerne l'utilisation de conjugués PEG-IFN- alpha , en association avec la ribavirine, pour fabriquer des médicaments destinés à traiter les infections chroniques par le virus de l'hépatite C. La présente invention concerne également une méthode permettant de traiter les infections chroniques par le virus de l'hépatite C chez des patients nécessitant un tel traitement, ces méthodes consistant à administrer une quantité d'un conjugué PEG-IFN- alpha en association avec une quantité de ribavirine efficace pour traiter l'hépatite C.
Zahm Friederike
F. Hoffmann-La Roche Ag
Gowling Lafleur Henderson Llp
LandOfFree
Use of peg-ifn-alpha and ribavirin for the treatment of... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Use of peg-ifn-alpha and ribavirin for the treatment of..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Use of peg-ifn-alpha and ribavirin for the treatment of... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1766739